The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung
NCT03595891
·
clinicaltrials.gov ↗
COMPLETED
Status
660
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Embolism (PE)
Pulmonary Thromboembolism
Interventions
OTHER:
Non-Interventional
Sponsor
Bristol-Myers Squibb